{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:29:10Z","timestamp":1794857350631,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>MDC1 is a key protein in DNA damage signaling. When DNA double-strand breaks (DSBs) occur, MDC1 localizes to the sites of DNA damage to promote the recruitment of other factors, including the 53BP1-mediated DSB repair pathway. By studying mechanisms of poly (ADP-ribose) polymerase inhibitor (PARPi) resistance in BRCA2; p53-deficient mouse mammary tumors, we identified a thus far unknown role of MDC1 in replication fork biology. Our results show that MDC1 localizes at active replication forks during normal DNA replication and regulates replication fork progression. It suppresses spontaneous fork reversal and regulates fork nucleolytic processing thereby promoting sensitivity to PARPi and cisplatin. In this way, MDC1 loss improves DNA damage tolerance and causes chemoresistance in BRCA1\/2-deficient cells. We demonstrate that limiting MRE11 activity abolishes the reduced fork speed while MRE11 inhibition\/depletion overcomes PARPi resistance in these cells. Overall, our data provides new insights into the role of MDC1 in replication fork progression that mediates PARPi- and cisplatin-induced DNA damage, in addition to its role in DSB repair.<\/jats:p>","DOI":"10.1038\/s41388-025-03659-8","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T15:57:08Z","timestamp":1765987028000},"page":"491-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1\/2-deficient tumors"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-6061","authenticated-orcid":false,"given":"H\u00fclya","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Liptay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana S.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gogola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra A.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1791-1874","authenticated-orcid":false,"given":"Jonas A.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismar","family":"Klebic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Siffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4988-5940","authenticated-orcid":false,"given":"Paola","family":"Francica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8756-659X","authenticated-orcid":false,"given":"Israel","family":"Salguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske","family":"de Korte-Grimmerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9317-7937","authenticated-orcid":false,"given":"Stephen P.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9264-9792","authenticated-orcid":false,"given":"Jos","family":"Jonkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3847-8133","authenticated-orcid":false,"given":"Massimo","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-5258","authenticated-orcid":false,"given":"Diego","family":"Dibitetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2044-9844","authenticated-orcid":false,"given":"Sven","family":"Rottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Helleday T, et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005;434:913\u20137.","journal-title":"Nature"},{"key":"3659_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt A, Johnson DA, Knights C, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917\u201321.","journal-title":"Nature"},{"key":"3659_CR3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","volume":"30","author":"J Mateo","year":"2019","unstructured":"Mateo J, Lord CJ, Serra V, Tutt A, Balma\u00f1a J, de Bono JS, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30:1437\u201347.","journal-title":"Ann Oncol"},{"key":"3659_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers J, Meuwissen R, van der Gulden H, Peterse H, Berns A, et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet. 2001;29:418\u201325.","journal-title":"Nat Genet"},{"key":"3659_CR5","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.1073\/pnas.0702969104","volume":"104","author":"X Liu","year":"2017","unstructured":"Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Jonkers J, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci USA. 2017;104:12111\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3659_CR6","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ccell.2018.05.008","volume":"33","author":"E Gogola","year":"2018","unstructured":"Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, Rottenberg S, et al. Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality. Cancer Cell. 2018;33:1078\u201393.e12.","journal-title":"Cancer Cell"},{"key":"3659_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2024.06.008","volume":"10","author":"D Dibitetto","year":"2024","unstructured":"Dibitetto D, Widmer CA, Rottenberg S. PARPi, BRCA, and gaps: controversies and future research. Trends cancer. 2024;10:857\u201369.","journal-title":"Trends cancer"},{"key":"3659_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108068","volume":"32","author":"P Francica","year":"2020","unstructured":"Francica P, Mutlu M, Blomen VA, Oliveira C, Nowicka Z, Rottenberg S, et al. Functional radiogenetic profiling implicates ERCC6L2 in non-homologous end joining. Cell Rep. 2020;32:108068.","journal-title":"Cell Rep"},{"key":"3659_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-cancerbio-030617-050232","volume":"3","author":"E Gogola","year":"2019","unstructured":"Gogola E, Rottenberg S, Jonkers J. Resistance to PARP inhibitors: lessons from preclinical models of BRCA-associated cancer. Annu Rev Cancer Biol. 2019;3:235\u201354.","journal-title":"Annu Rev Cancer Biol"},{"key":"3659_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature18325","volume":"535","author":"A Ray Chaudhuri","year":"2016","unstructured":"Ray Chaudhuri A, Callen E, Ding X, Gogola E, Duarte AA, Nussenzweig A, et al. Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature. 2016;535:382\u20137.","journal-title":"Nature"},{"key":"3659_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48715-1","volume":"15","author":"D Dibitetto","year":"2024","unstructured":"Dibitetto D, Liptay M, Vivalda F, Dogan H, Gogola E, Rottenberg S, et al. H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours. Nat Commun. 2024;15:4430.","journal-title":"Nat Commun"},{"key":"3659_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nsmb.2501","volume":"20","author":"M Berti","year":"2013","unstructured":"Berti M, Ray Chaudhuri A, Thangavel S, Gomathinayagam S, Kenig S, Vindigni A, et al. Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition. Nat Struct Mol Biol. 2013;20:347\u201354.","journal-title":"Nat Struct Mol Biol"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1083\/jcb.201406099","volume":"208","author":"R Zellweger","year":"2015","unstructured":"Zellweger R, Dalcher D, Mutreja K, Berti M, Vindigni A, Lopes M, et al. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J Cell Biol. 2015;208:563\u201379.","journal-title":"J Cell Biol"},{"key":"3659_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41586-018-0261-5","volume":"559","author":"A Maya-Mendoza","year":"2018","unstructured":"Maya-Mendoza A, Moudry P, Merchut-Maya JM, Lee M, Strauss R, Bartek J. High speed of fork progression induces DNA replication stress and genomic instability. Nature. 2018;559:279\u201384.","journal-title":"Nature"},{"key":"3659_CR15","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.celrep.2018.04.046","volume":"23","author":"M Barazas","year":"2018","unstructured":"Barazas M, Annunziato S, Pettitt SJ, de Krijger I, Ghezraoui H, Rottenberg S, et al. The CST complex mediates end protection at double-strand breaks and promotes PARP inhibitor sensitivity in brca1-deficient cells. Cell Rep. 2018;23:2107\u201318.","journal-title":"Cell Rep"},{"key":"3659_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41556-018-0140-1","volume":"20","author":"H Dev","year":"2018","unstructured":"Dev H, Chiang TW, Lescale C, de Krijger I, Martin AG, Jackson SP, et al. Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. Nat Cell Biol. 2018;20:954\u201365.","journal-title":"Nat Cell Biol"},{"key":"3659_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/2159-8290.CD-12-0049","volume":"3","author":"JE Jaspers","year":"2013","unstructured":"Jaspers JE, Kersbergen A, Boon U, Sol W, van Deemter L, Rottenberg S, et al. Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors. Cancer Discov. 2013;3:68\u201381.","journal-title":"Cancer Discov"},{"key":"3659_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-018-0340-7","volume":"560","author":"SM Noordermeer","year":"2018","unstructured":"Noordermeer SM, Adam S, Setiaputra D, Barazas M, Pettitt SJ, Durocher D, et al. The shieldin complex mediates 53BP1-dependent DNA repair. Nature. 2018;560:117\u201321.","journal-title":"Nature"},{"key":"3659_CR19","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1158\/1078-0432.CCR-07-4953","volume":"14","author":"B Evers","year":"2008","unstructured":"Evers B, Drost R, Schut E, de Bruin M, Van der Burg E, Jonkers J, et al. Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin. Clin Cancer Res. 2008;14:3916\u201325.","journal-title":"Clin Cancer Res"},{"key":"3659_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/1078-0432.CCR-09-2434","volume":"16","author":"B Evers","year":"2010","unstructured":"Evers B, Schut E, Van der Burg E, Braumuller TM, Egan DA, Bouwman P, et al. A high-throughput pharmaceutical screen identifies compounds with specific toxicity against BRCA2-deficient tumors. Clin Cancer Res. 2010;16:99\u2013108.","journal-title":"Clin Cancer Res"},{"key":"3659_CR21","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1038\/s41467-019-12929-5","volume":"10","author":"I Salguero","year":"2019","unstructured":"Salguero I, Belotserkovskaya R, Coates J, Sczaniecka-Clift M, Wilson MD, Jackson SP. MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance. Nat Comm. 2019;10:5191 .","journal-title":"Nat Comm"},{"key":"3659_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41586-018-0291-z","volume":"559","author":"M Zimmermann","year":"2018","unstructured":"Zimmermann M, Murina O, Reijns MAM, Agathanggelou A, Challis R, McEwan A, et al. CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions. Nature. 2018;559:285\u20139.","journal-title":"Nature"},{"key":"3659_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nmeth.4535","volume":"15","author":"AA Duarte","year":"2018","unstructured":"Duarte AA, Gogola E, Sachs N, Barazas M, Annunziato S, Rottenberg S, et al. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance. Nat Methods. 2018;15:134\u201340.","journal-title":"Nat Methods"},{"key":"3659_CR24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783\u20134.","journal-title":"Nat Methods"},{"key":"3659_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature14328","volume":"521","author":"G Xu","year":"2015","unstructured":"Xu G, Chapman JR, Brandsma I, Yuan J, Mistrik M, Rottenberg S, et al. REV7 counteracts DNA double-strand break resection and affects PARP inhibition. Nature. 2015;521:541\u20134.","journal-title":"Nature"},{"key":"3659_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li W, Xu H, Xiao T, Cong L, Love MI, Liu XS, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 2014;15:554.","journal-title":"Genome Biol"},{"key":"3659_CR27","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.celrep.2015.08.037","volume":"12","author":"A Prahallad","year":"2015","unstructured":"Prahallad A, Heynen GJJE, Germano G, Willems SM, Evers B, Bernards R, et al. PTPN11 Is a central node in intrinsic and acquired resistance to targeted cancer drugs. Cell Rep. 2015;12:1978\u201385.","journal-title":"Cell Rep"},{"key":"3659_CR28","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42:e168\u2013e168.","journal-title":"Nucleic Acids Res"},{"key":"3659_CR29","doi-asserted-by":"publisher","first-page":"e92444","DOI":"10.1371\/journal.pone.0092444","volume":"9","author":"C Guzm\u00e1n","year":"2014","unstructured":"Guzm\u00e1n C, Bagga M, Kaur A, Westermarck J, Abankwa D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLoS ONE. 2014;9:e92444.","journal-title":"PLoS ONE"},{"key":"3659_CR30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.molcel.2018.07.011","volume":"71","author":"JA Schmid","year":"2018","unstructured":"Schmid JA, Berti M, Walser F, Raso MC, Schmid F, Penengo L, et al. Histone ubiquitination by the DNA damage response is required for efficient DNA replication in unperturbed S phase. Mol Cell. 2018;71:897\u2013910.e8.","journal-title":"Mol Cell"},{"key":"3659_CR31","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.celrep.2018.08.019","volume":"24","author":"K Mutreja","year":"2018","unstructured":"Mutreja K, Krietsch J, Hess J, Ursich S, Berti M, Lopes M. ATR-mediated global fork slowing and reversal assist fork traverse and prevent chromosomal breakage at DNA interstrand cross-links. Cell Rep. 2018;24:2629\u201342.e5.","journal-title":"Cell Rep"},{"key":"3659_CR32","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1158\/0008-5472.CAN-15-3240","volume":"76","author":"LO O\u2019Connor","year":"2016","unstructured":"O\u2019Connor LO, Rulten SL, Cranston AN, Odedra R, Brown H, O\u2019Connor MJ, et al. The PARP inhibitor AZD2461 provides insights into the role of PARP3 inhibition for both synthetic lethality and tolerability with chemotherapy in preclinical models. Cancer Res. 2016;76:6084\u201394.","journal-title":"Cancer Res"},{"key":"3659_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.201010026","volume":"193","author":"J Wang","year":"2011","unstructured":"Wang J, Gong Z, Chen J. MDC1 collaborates with TopBP1 in DNA replication checkpoint control. J Cell Biol. 2011;193:267\u201373.","journal-title":"J Cell Biol"},{"key":"3659_CR34","doi-asserted-by":"publisher","first-page":"11200","DOI":"10.1073\/pnas.0802885105","volume":"105","author":"L Wu","year":"2008","unstructured":"Wu L, Luo K, Lou Z, Chen J. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. PNAS. 2008;105:11200\u20135.","journal-title":"PNAS"},{"key":"3659_CR35","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.1005031107","volume":"107","author":"E Petermann","year":"2010","unstructured":"Petermann E, Woodcock M, Helleday T. Chk1 promotes replication fork progression by controlling replication initiation. PNAS. 2010;107:16090\u20135.","journal-title":"PNAS"},{"key":"3659_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201208060","volume":"201","author":"Y Zhong","year":"2013","unstructured":"Zhong Y, Nellimoottil T, Peace JM, Knott SRV, Villwock SK, Aparicio OM, et al. The level of origin firing inversely affects the rate of replication fork progression. J Cell Biol. 2013;201:373\u201383.","journal-title":"J Cell Biol"},{"key":"3659_CR37","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41467-017-01401-x","volume":"8","author":"T Moiseeva","year":"2017","unstructured":"Moiseeva T, Hood B, Schamus S, O\u2019Connor MJ, Conrads TP, Bakkenist CJ. ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1. Nat Comm. 2017;8:1392.","journal-title":"Nat Comm"},{"key":"3659_CR38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb1145","volume":"6","author":"D Shechter","year":"2004","unstructured":"Shechter D, Costanzo V, Gautier J. ATR and ATM regulate the timing of DNA replication origin firing. Nat Cell Biol. 2004;6:648\u201355.","journal-title":"Nat Cell Biol"},{"key":"3659_CR39","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.molcel.2017.08.010","volume":"67","author":"M Vujanovic","year":"2017","unstructured":"Vujanovic M, Krietsch J, Raso MC, Terraneo N, Penengo L, Lopes M, et al. Replication fork slowing and reversal upon DNA damage require PCNA polyubiquitination and ZRANB3 DNA translocase activity. Mol Cell. 2017;67:882\u201390.e5.","journal-title":"Mol Cell"},{"key":"3659_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm3935","volume":"16","author":"KJ Neelsen","year":"2015","unstructured":"Neelsen KJ, Lopes M. Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat Rev Mol Cell Biol. 2015;16:207\u201320.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3659_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba5974","volume":"6","author":"LG Bennett","year":"2020","unstructured":"Bennett LG, Wilkie AM, Antonopoulou E, Ceppi I, Sanchez A, Cejka P, et al. MRNIP is a replication fork protection factor. Sci Adv. 2020;6:eaba5974.","journal-title":"Sci Adv"},{"key":"3659_CR42","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41467-017-01180-5","volume":"8","author":"D Lema\u00e7on","year":"2017","unstructured":"Lema\u00e7on D, Jackson J, Quinet A, Brickner JR, Li S, Vindigni A, et al. MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells. Nat Comm. 2017;8:860.","journal-title":"Nat Comm"},{"key":"3659_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948920","volume":"21","author":"MD Rainey","year":"2020","unstructured":"Rainey MD, Quinlan A, Cazzaniga C, Mijic S, Martella O, Santocanale C, et al. CDC7 kinase promotes MRE11 fork processing, modulating fork speed and chromosomal breakage. EMBO Rep. 2020;21:e48920.","journal-title":"EMBO Rep"},{"key":"3659_CR44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202002175","volume":"219","author":"MC Raso","year":"2020","unstructured":"Raso MC, Djoric N, Walser F, Hess S, Schmid FM, Penengo L, et al. Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage. J Cell Biol. 2020;219:e202002175.","journal-title":"J Cell Biol"},{"key":"3659_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1101\/gad.178459.111","volume":"26","author":"R B\u00e9tous","year":"2012","unstructured":"B\u00e9tous R, Mason AC, Rambo RP, Bansbach CE, Badu-Nkansah A, Cortez D, et al. SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication. Genes Dev. 2012;26:151\u201362.","journal-title":"Genes Dev"},{"key":"3659_CR46","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.molcel.2017.07.001","volume":"67","author":"AM Kolinjivadi","year":"2017","unstructured":"Kolinjivadi AM, Sannino V, De Antoni A, Zadorozhny K, Krejci L, Costanzo V, et al. Smarcal1-mediated fork reversal triggers Mre11-dependent degradation of nascent DNA in the absence of Brca2 and stable Rad51 nucleofilaments. Mol Cell. 2017;67:867\u201381.e7.","journal-title":"Mol Cell"},{"key":"3659_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41580-020-0257-5","volume":"21","author":"M Berti","year":"2020","unstructured":"Berti M, Cortez D, Lopes M. The plasticity of DNA replication forks in response to clinically relevant genotoxic stress. Nat Rev Mol Cell Biol. 2020;21:633\u201351.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3659_CR48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/embor.2008.103","volume":"9","author":"JR Chapman","year":"2008","unstructured":"Chapman JR, Jackson SP. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep. 2008;9:795\u2013801.","journal-title":"EMBO Rep"},{"key":"3659_CR49","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1016\/j.molcel.2022.08.028","volume":"82","author":"D Dibitetto","year":"2022","unstructured":"Dibitetto D, Marshall S, Sanchi A, Liptay M, Rottenberg S, Smolka MB, et al. DNA-PKcs promotes fork reversal and chemoresistance. Mol Cell. 2022;82:3932\u201342.e6.","journal-title":"Mol Cell"},{"key":"3659_CR50","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.molcel.2018.09.014","volume":"72","author":"S Przetocka","year":"2018","unstructured":"Przetocka S, Porro A, Bolck HA, Walker C, Lezaja A, Sartori A, et al. A. CtIP-mediated fork protection synergizes with BRCA1 to suppress genomic instability upon DNA replication stress. Mol Cell. 2018;72:568\u201382.e6.","journal-title":"Mol Cell"},{"key":"3659_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ebiom.2016.02.043","volume":"6","author":"W Liu","year":"2016","unstructured":"Liu W, Zhou M, Li Z, Li H, Polaczek P, Shen B, et al. A selective small molecule DNA2 inhibitor for sensitization of human cancer cells to chemotherapy. EBioMedicine. 2016;6:73\u201386.","journal-title":"EBioMedicine"},{"key":"3659_CR52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nchembio.2148","volume":"12","author":"JC Exell","year":"2016","unstructured":"Exell JC, Thompson MJ, Finger LD, Shaw SJ, Durant ST, Grasby JA, et al. Cellularly active N-hydroxyurea FEN1 inhibitors block substrate entry to the active site. Nat Chem Biol. 2016;12:815\u201321.","journal-title":"Nat Chem Biol"},{"key":"3659_CR53","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1016\/j.molcel.2025.08.017","volume":"85","author":"M Peng","year":"2025","unstructured":"Peng M, Lee S, Nair HG, MacGilvary N, Cong K, Cantor SB, et al. RAD51 is chromatin enriched and targetable in BRCA1-deficient cells. Mol Cell. 2025;85:3373\u201387.e6.","journal-title":"Mol Cell"},{"key":"3659_CR54","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.cell.2005.09.038","volume":"123","author":"M Stucki","year":"2005","unstructured":"Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell. 2005;123:1213\u201326.","journal-title":"Cell"},{"key":"3659_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molcel.2005.11.025","volume":"21","author":"Z Lou","year":"2006","unstructured":"Lou Z, Minter-Dykhouse K, Franco S, Gostissa M, Rivera MA, Chen J, et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol Cell. 2006;21:187\u2013200.","journal-title":"Mol Cell"},{"key":"3659_CR56","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.molcel.2020.12.025","volume":"81","author":"K Nakamura","year":"2021","unstructured":"Nakamura K, Kustatscher G, Alabert C, H\u00f6dl M, Rappsilber J, Groth A, et al. Proteome dynamics at broken replication forks reveal a distinct ATM-directed repair response suppressing DNA double-strand break ubiquitination. Mol Cell. 2021;81:1084\u201399.e6.","journal-title":"Mol Cell"},{"key":"3659_CR57","doi-asserted-by":"publisher","first-page":"31458","DOI":"10.1074\/jbc.M113.511337","volume":"288","author":"BM Sirbu","year":"2013","unstructured":"Sirbu BM, McDonald WH, Dungrawala H, Badu-Nkansah A, Kavanaugh GM, Cortez D, et al. Identification of proteins at active, stalled, and collapsed replication forks using isolation of proteins on nascent DNA (iPOND) coupled with mass spectrometry. J Biol Chem. 2013;288:31458\u201367.","journal-title":"J Biol Chem"},{"key":"3659_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114024","volume":"43","author":"P Ubieto-Capella","year":"2024","unstructured":"Ubieto-Capella P, Xim\u00e9nez-Emb\u00fan P, Gim\u00e9nez-Llorente D, Losada A, Mu\u00f1oz J, M\u00e9ndez JA. rewiring of DNA replication mediated by MRE11 exonuclease underlies primed-to-na\u00efve cell de-differentiation. Cell Rep. 2024;43:114024.","journal-title":"Cell Rep"},{"key":"3659_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111979","volume":"42","author":"Pappas G","year":"2023","unstructured":"Pappas G, Munk SHN, Watanabe K, Thomas Q, Galanos P, Bartek J, et al. MDC1 maintains active elongation complexes of RNA polymerase II. Cell Rep. 2023;42:111979.","journal-title":"Cell Rep"},{"key":"3659_CR60","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/s41467-017-01164-5","volume":"8","author":"S Mijic","year":"2017","unstructured":"Mijic S, Zellweger R, Chappidi N, Berti M, Jacobs K, Janscak P, et al. Replication fork reversal triggers fork degradation in BRCA2-defective cells. Nat Comm. 2017;8:859.","journal-title":"Nat Comm"},{"key":"3659_CR61","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s44318-024-00043-2","volume":"43","author":"C Andronikou","year":"2024","unstructured":"Andronikou C, Burdova K, Dibitetto D, Lieftink C, Malzer E, Kuiken HJ, et al. PARG-deficient tumor cells have an increased dependence on EXO1\/FEN1-mediated DNA repair. EMBO J. 2024;43:1015\u201342.","journal-title":"EMBO J"},{"key":"3659_CR62","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00472-17","volume":"38","author":"J Her","year":"2018","unstructured":"Her J, Ray C, Altshuler J, Zheng H, Bunting SF. 53BP1 mediates ATR-Chk1 signaling and protects replication forks under conditions of replication stress. Mol Cell Biol. 2018;38:e00472-17.","journal-title":"Mol Cell Biol"},{"key":"3659_CR63","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1038\/s41467-019-11246-1","volume":"10","author":"C Mukherjee","year":"2019","unstructured":"Mukherjee C, Tripathi V, Manolika EM, Heijink A, Ricc G, Ray Chaudhuri A, et al. RIF1 promotes replication fork protection and efficient restart to maintain genome stability. Nat Commun. 2019;10:3287.","journal-title":"Nat Commun"},{"key":"3659_CR64","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.30523","volume":"6","author":"Y Xu","year":"2017","unstructured":"Xu Y, Ning S, Wei Z, Xu R, Xu X, Xu D, et al. 53BP1 and BRCA1 control pathway choice for stalled replication restart. Elife. 2017;6:e30523.","journal-title":"Elife"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03659-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:01:32Z","timestamp":1768863692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,10]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03659-8","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}